GL1X · GenesisL1 explorer

Research workbench

Burg (holo) in complex with 2-hydroxy-2-(HYDROXY(ISOPROPYL)AMINO) acetate (11): biosynthesis of cyclopropanolrings in bacterial toxins

Analyse Burg (holo) in complex with 2-hydroxy-2-(HYDROXY(ISOPROPYL)AMINO) acetate (11)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7PCL
Type
protein
Length
681 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ketol-acid reductoisomerase
EC
1.1.1.86
UniProt
Q2T3G7
Ligands
NAD, 76I, MG
Pockets
4 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 56% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AKetol-acid reductoisomerase (EC 1.1.1.86)protein34056% helix, 11% strandQ2T3G7
BKetol-acid reductoisomerase (EC 1.1.1.86)protein34156% helix, 12% strandQ2T3G7

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · 2 copies · chains A, B
  • 76I · (2S)-2-oxidanyl-2-[oxidanyl(propan-2-yl)amino]ethanoic acid · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15170.780.8561NAD, MG, 76I
25470.780.846276I, NAD, MG
35200.700.7942empty
4650.330.7719empty

Interfaces

1 interface between chains.

  • A–B · 6545 Ų buried · 88 hydrogen bonds · protein-protein

Compared structures

  • 7PCL · BurG (holo) in complex with 2-hydroxy-2-(hydroxy(isopropyl)amino)acetate (11)… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.